Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
12 studies found for:    LRP5
Show Display Options
Rank Status Study
1 Completed Clinical Assessment of Patients With High Bone Mass Due to Mutation in Lrp5
Condition: Osteopetrosis
2 Completed Radiological Biological Genetic and Micro-architectural Bone Determinants of Fractures in Men With Low Bone Mineral Density
Condition: Osteoporosis
Interventions: Other: Radiology;   Other: Biological, biochemical and genetic samples
3 Active, not recruiting Trial of Lithium Carbonate for Treatment of Osteoporosis-pseudoglioma Syndrome
Condition: Osteoporosis Pseudoglioma
Intervention: Drug: Lithium
4 Completed Efficacy and Tolerance of a Derivative of Salicylic Acid and 5% Benzoyl Peroxide in Facial Acne Vulgaris
Condition: Acne Vulgaris
Interventions: Drug: Lipo Hydroxy Acid;   Drug: 5% benzoyl peroxide gel
5 Active, not recruiting Imatinib Mesylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia Who Have Received Chemotherapy
Condition: Leukemia
Interventions: Drug: imatinib mesylate;   Genetic: gene expression analysis;   Genetic: mutation analysis;   Genetic: polymerase chain reaction;   Other: flow cytometry;   Procedure: biopsy
6 Recruiting Chemotherapy and Radiation Therapy With or Without Metformin Hydrochloride in Treating Patients With Stage III Non-small Cell Lung Cancer
Conditions: Adenocarcinoma of the Lung;   Adenosquamous Cell Lung Cancer;   Bronchoalveolar Cell Lung Cancer;   Large Cell Lung Cancer;   Recurrent Non-small Cell Lung Cancer;   Squamous Cell Lung Cancer;   Stage IIIA Non-small Cell Lung Cancer;   Stage IIIB Non-small Cell Lung Cancer
Interventions: Drug: paclitaxel;   Drug: carboplatin;   Radiation: 3-dimensional conformal radiation therapy;   Radiation: intensity-modulated radiation therapy;   Radiation: volumetric-modulated arc therapy;   Drug: metformin hydrochloride;   Other: laboratory biomarker analysis
7 Recruiting Chemotherapy Before Surgery and Tissue Sample Collection in Patients With Stage IIA-IIIC Breast Cancer
Conditions: Stage II Breast Cancer;   Stage IIIA Breast Cancer;   Stage IIIB Breast Cancer;   Stage IIIC Breast Cancer;   Stage IV Breast Cancer
Interventions: Drug: paclitaxel;   Biological: trastuzumab;   Drug: doxorubicin hydrochloride;   Drug: cyclophosphamide;   Other: laboratory biomarker analysis;   Other: cytology specimen collection procedure
8 Recruiting A Study to Test the Safety/Tolerability of Increasing Doses of LNP1892 Versus Placebo in Healthy Male/Female Subjects
Condition: Healthy
Interventions: Drug: LNP1892;   Drug: Placebo
9 Completed Docetaxel and Carboplatin With or Without Trastuzumab Before Surgery in Treating Women With Locally Advanced Breast Cancer
Condition: Breast Cancer
Interventions: Biological: trastuzumab;   Drug: carboplatin;   Drug: docetaxel
10 Recruiting GRN1005 Alone or in Combination With Trastuzumab in Breast Cancer Patients With Brain Metastases
Conditions: Breast Cancer;   Brain Metastases
Interventions: Drug: GRN1005;   Drug: Trastuzumab;   Drug: 18F-FLT
11 Terminated Daily Use of Lipikar Balm AP From Birth in Infants at High Risk of Developing Atopic Dermatitis
Conditions: Atopic Dermatitis;   Eczema;   Asthma;   Food Allergies;   Allergic Rhinitis
Intervention: Drug: Lipikar Balm AP
12 Completed
Has Results
Comparison of Redermic, Rejuva-A and Combination of Both Redermic and Rejuva-A in Subjects With Signs of Aging
Condition: Skin Aging
Interventions: Other: Redermic;   Drug: Tretinoin (Rejuva-A)

Indicates status has not been verified in more than two years